Rajasekharan Somasundaram Selected Research

Rajasekharan Somasundaram Research Topics

Disease

37	Melanoma (Melanoma, Malignant) 01/2022 - 03/2003
35	Neoplasms (Cancer) 01/2022 - 04/2002
6	Colorectal Neoplasms (Colorectal Cancer) 09/2010 - 04/2002
4	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2009
4	Carcinoma (Carcinomatosis) 09/2010 - 04/2003
3	Breast Neoplasms (Breast Cancer) 01/2022 - 11/2004
3	Glioma (Gliomas) 04/2007 - 04/2003
2	Inflammation (Inflammations) 01/2019 - 01/2013
1	Triple Negative Breast Neoplasms 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Experimental Melanoma 02/2016
1	Disease Progression 01/2014
1	Squamous Cell Carcinoma of Head and Neck 12/2013
1	Rectal Neoplasms (Rectal Cancer) 09/2010
1	Neuroectodermal Tumors (Neuroectodermal Tumor) 04/2009
1	Neuroblastoma 04/2009
1	Glioblastoma (Glioblastoma Multiforme) 04/2009
1	Ulcerative Colitis 05/2006

Drug/Important Bio-Agent (IBA)

13	AntigensIBA 02/2016 - 04/2002
10	AntibodiesIBA 03/2016 - 04/2002
8	ChemokinesIBA 12/2021 - 05/2005
8	VaccinesIBA 02/2016 - 04/2002
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2003
5	Peptides (Polypeptides)IBA 02/2016 - 03/2006
5	Chemokine ReceptorsIBA 04/2009 - 05/2005
4	CollagenIBA 01/2022 - 05/2005
4	LigandsIBA 04/2014 - 05/2005
3	Immune Checkpoint InhibitorsIBA 01/2021 - 03/2016
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2015
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018 - 12/2010
3	CytokinesIBA 04/2009 - 04/2003
3	Monoclonal AntibodiesIBA 07/2008 - 04/2002
2	Immunoglobulin G (IgG)IBA 01/2022 - 07/2008
2	Programmed Cell Death 1 ReceptorIBA 12/2021 - 03/2016
2	IpilimumabIBA 01/2015 - 03/2013
2	Conditioned Culture MediaIBA 04/2014 - 07/2012
2	Rituximab (Mabthera)FDA Link 11/2012 - 05/2012
2	GD2 gangliosideIBA 07/2008 - 03/2003
2	Epithelial Cell Adhesion MoleculeIBA 05/2006 - 04/2002
2	HLA Antigens (Human Leukocyte Antigens)IBA 03/2006 - 11/2005
2	Anti-Idiotypic AntibodiesIBA 03/2003 - 04/2002
1	Glycogen Synthase (Synthase I)IBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Sunitinib (Sutent)FDA Link 12/2021
1	indolepropanol phosphate (IPP)IBA 12/2021
1	resiquimodIBA 12/2021
1	Imatinib Mesylate (Gleevec)FDA Link 12/2021
1	RNA (Ribonucleic Acid)IBA 12/2021
1	ProdrugsIBA 01/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	NucleosidesIBA 10/2018
1	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2018
1	alpha-2'-deoxythioguanosineIBA 10/2018
1	Drug CombinationsIBA 01/2018
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2017
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017
1	InterferonsIBA 02/2016
1	OvalbuminIBA 02/2016
1	HLA-B57 antigenIBA 01/2015
1	NivolumabIBA 01/2015
1	Cancer VaccinesIBA 01/2015
1	Indomethacin (Indometacin)FDA LinkGeneric 05/2014
1	Chemotactic FactorsIBA 04/2014
1	Macrophage Colony-Stimulating FactorIBA 04/2014
1	Matrix Metalloproteinases (MMPs)IBA 07/2012
1	Glycoproteins (Glycoprotein)IBA 07/2012
1	IgA receptor (protein B)IBA 07/2012
1	Indicators and Reagents (Reagents)IBA 01/2012
1	CCR2 ReceptorsIBA 03/2011
1	Proto-Oncogene Proteins A-rafIBA 12/2010
1	Protein Isoforms (Isoforms)IBA 12/2010
1	NucleophosminIBA 09/2010
1	HLA-A1 Antigen (HLA A1 Antigen)IBA 09/2010
1	Immunoglobulin M (IgM)IBA 07/2008
1	keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA 07/2008
1	saponin QA-21V1 (QS21)IBA 07/2008
1	rat ribosomal protein L8IBA 04/2007
1	Histocompatibility Antigens Class IIIBA 04/2007
1	Neoplasm Antigens (Tumor Antigens)IBA 03/2007
1	Chemokine CXCL11IBA 03/2007
1	Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA 05/2006
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 03/2006
1	CCR ReceptorsIBA 02/2006
1	CC ChemokinesIBA 02/2006
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2005
1	CXC ChemokinesIBA 05/2005
1	Chemokine CXCL12IBA 05/2005
1	Collagen Type I (Type I Collagen)IBA 05/2005
1	Epidermal Growth Factor (EGF)IBA 11/2004
1	ErbB Receptors (EGF Receptor)IBA 11/2004
1	Interleukin-2 (IL2)IBA 09/2003

Therapy/Procedure

26	Therapeutics 01/2022 - 04/2003
5	Immunotherapy 12/2021 - 07/2008
2	Drug Therapy (Chemotherapy) 03/2016 - 05/2012
1	Salvage Therapy 01/2018
1	Aftercare (After-Treatment) 02/2016
1	Biological Therapy 03/2013
1	Radiotherapy 05/2012